Drug name - Aristada Initio Kit

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10112903 ALKERMES INC Heterocyclic compounds for the treatment of neurological and psychological disorders
Jun, 2030

(7 years from now)

US8431576 ALKERMES INC Heterocyclic compounds for the treatment of neurological and psychological disorders
Oct, 2030

(8 years from now)

EP2445502B1 ALKERMES INC Heterocyclic Compounds For The Treatment Of Neurological And Psychological Disorders
Jun, 2030

(7 years from now)

EP2445502A1 ALKERMES INC Heterocyclic Compounds For The Treatment Of Neurological And Psychological Disorders
Jun, 2030

(7 years from now)

EP2445343A1 ALKERMES INC Prodrugs Of Nh-Acidic Compounds
Jun, 2030

(7 years from now)

EP2445343B1 ALKERMES INC Prodrugs Of Nh-Acidic Compounds
Jun, 2030

(7 years from now)

EP2445502A4 ALKERMES INC Heterocyclic Compounds For The Treatment Of Neurological And Psychological Disorders
Jun, 2030

(7 years from now)

EP2445343A4 ALKERMES INC Prodrugs Of Nh-Acidic Compounds
Jun, 2030

(7 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8796276 ALKERMES INC Heterocyclic compounds for the treatment of neurological and psychological disorders Jun, 2030

(7 years from now)

US10688091 ALKERMES INC Aripiprazole prodrug composition Aug, 2035

(12 years from now)

US10849894 ALKERMES INC Aripiprazole prodrug composition Aug, 2035

(12 years from now)

US11154552 ALKERMES INC Aripiprazole prodrug composition Aug, 2035

(12 years from now)

US10016415 ALKERMES INC Aripiprazole prodrug compositions Sep, 2035

(12 years from now)

Drugs and Companies using ARIPIPRAZOLE LAUROXIL ingredient

Treatment: Treatment of schizophrenia

Dosage: SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
675MG/2.4ML SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.